ONLINE DATABASE SEARCH - OI-LS-291-MEMO
1. 42997 OI-LS-291; PUBMED-OI-3/9/2004
Temperature-Mediated Heteroduplex Analysis for Detection of pncA Mutations Associated with Pyrazinamide Resistance and Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by Denaturing High- Performance Liquid Chromatography
Mohamed, AM, BastoLa DR, Morlock, GP, Cooksey, RC, and Hinrichs, SH
J Clin Microbiol 2004. 42(3): 1016-1023
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15004047&dopt=abstract
2. 42998 OI-LS-291; PUBMED-OI-3/9/2004
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers
Pandey, R and Khuller, GK
J Antimicrob Chemother 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14998985&dopt=abstract
3. 42999 OI-LS-291; PUBMED-OI-3/9/2004
Design, Synthesis, and Evaluation of Aza-Peptide Epoxides as Selective and Potent Inhibitors of Caspases-1, -3, -6, and -8
James, KE, Asgian, JL, Li, ZZ, Ekici, OD, Rubin, JR, Mikolajczyk, J, Salvesen, GS, and Powers, JC
J Med Chem 2004. 47(6): 1553-1574
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14998341&dopt=abstract
4. 43000 OI-LS-291; SCIFINDER-OI-3/2/2004
Neonatal-mouse infectivity of intact Cryptosporidium parvum oocysts isolated after optimized in vitro excystation
Hou, L, Li, X, Dunbar, L, Moeller, R, Palermo, B, and Atwill, ER
Applied and Environmental Microbiology 2004. 70(1): 642-646
5. 43001 OI-LS-291; PUBMED-OI-3/9/2004
Highlights of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Prescott, LM
Body Posit 2002. 15(7): 16-20
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14989207&dopt=abstract
6. 43002 OI-LS-291; PUBMED-OI-3/9/2004
Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides
Carta, A, Loriga, M, Paglietti, G, Mattana, A, Fiori, PL, Mollicotti, P, Sechi, L, and Zanetti, S
Eur J Med Chem 2004. 39(2): 195-203
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14987828&dopt=abstract
7. 43003 OI-LS-291; PUBMED-OI-3/9/2004
Hepatitis C NS3 protease inhibition by peptidyl-alpha-ketoamide inhibitors: kinetic mechanism and structure
Liu, Y, Stoll, VS, Richardson, PL, Saldivar, A, Klaus, JL, MolLa A, Kohlbrenner, W, and Kati, WM
Arch Biochem Biophys 2004. 421(2): 207-16
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14984200&dopt=abstract
8. 43004 OI-LS-291; PUBMED-OI-3/9/2004
In vitro activities of 3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-ones against common and emerging yeasts and molds
Buchta, V, Pour, M, Kubanova, P, Silva, L, Votruba, I, Voprsalova, M, Schiller, R, Fakova, H, and Spulak, M
Antimicrob Agents Chemother 2004. 48(3): 873-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14982778&dopt=abstract
9. 43005 OI-LS-291; PUBMED-OI-3/9/2004
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis
Xu, ZQ, Barrow, WW, Suling, WJ, Westbrook, L, Barrow, E, Lin, YM, and Flavin, MT
Bioorg Med Chem 2004. 12(5): 1199-207
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14980631&dopt=abstract
10. 43006 OI-LS-291; PUBMED-OI-3/9/2004
The search for new sterilizing anti-tuberculosis drugs
Mitchison, DA
Front Biosci 2004. 9: 1059-72
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14977529&dopt=abstract
11. 43007 OI-LS-291; SCIFINDER-OI-3/2/2004
Preparation of antimicrobial bis(quaternary ammonium salts) and their uses((Toa Gosei Chemical Industry Co., Ltd. Japan)
Shibata, Shigeyuki, Kano, Muneaki, Tanaka, Yoichi, Nagata, Toshiyuki, and Koma, Hiroki
PATENT: JP 2004026722 A2; ISSUE DATE: 20040129
APPLICATION: 2002-54636; PP: 17 pp.
12. 43008 OI-LS-291; PUBMED-OI-3/9/2004
Mechanisms of hepatitis C virus infection
Moriishi, K and Matsuura, Y
Antivir Chem Chemother 2003. 14(6): 285-97
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14968935&dopt=abstract
13. 43009 OI-LS-291; SCIFINDER-OI-3/2/2004
Fungicides PF1237A, B, and M manufacture with Fusarium((Meiji Seika Kaisha, Ltd. Japan)
Yaguchi, Takashi, Ueda, Masaru, Fushimi, Hideki, Amano, Shoichi, and Iida, Maiko
PATENT: WO 2004013342 A1; ISSUE DATE: 20040212
APPLICATION: 2003; PP: 22 pp.
14. 43010 OI-LS-291; SCIFINDER-OI-3/2/2004
2-Mercaptopyridine N-oxide derivative, and antimicrobials and antimicrobial compositions containing it ((API Corporation, Japan)
Suga, Mamoru, Ishimaru, Katsutoshi, Sato, Toshio, and Takahashi, Hideo
PATENT: JP 2004043421 A2; ISSUE DATE: 20040212
APPLICATION: 2002-42025; PP: 9 pp.
15. 43011 OI-LS-291; SCIFINDER-OI-3/2/2004
Antifungal susceptibilities of Cryptococcus neoformans
Archibald, Lennox K, Tuohy, Marion J, Wilson, Deborah A, Nwanyanwu, Okey, Kazembe, Peter N, Tansuphasawadikul, Somsit, Eampokalap, Boonchuay, Chaovavanich, Achara, Reller, LBarth, Jarvis, William R, Hall, Gerri S, and Procop, Gary W
Emerging Infectious Diseases 2004. 10(1): 143-145
16. 43012 OI-LS-291; SCIFINDER-OI-3/2/2004
Antimicrobial theta defensins, analogs thereof, and methods of use((The Regents of the University of California, A California Corporation USA)
Selsted, Michael E and Tran, Dat Q
PATENT: US 2004014669 A1; ISSUE DATE: 20040122
APPLICATION: 2003-34499; PP: 46 pp.
17. 43013 OI-LS-291; SCIFINDER-OI-3/2/2004
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans
Miller, JL, Schell, WA, Wills, EA, Toffaletti, DL, Boyce, M, Benjamin, DK Jr, Bartroli, J, and Perfect, JR
Antimicrobial Agents and Chemotherapy 2004. 48(2): 384-387
18. 43014 OI-LS-291; WOS-OI-2/29/2004
Chips with everything: DNA microarrays in infectious diseases
Bryant, PA, Venter, D, Robins-Browne, R, and Curtis, N
LANCET INFECT DIS 2004. 4(2): 100-111
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188766100021
19. 43015 OI-LS-291; SCIFINDER-OI-3/2/2004
New 2,4-Diamino-5-(2',5'-substituted benzyl)pyrimidines as Potential Drugs against Opportunistic Infections of AIDS and Other Immune Disorders. Synthesis and Species-Dependent Antifolate Activity
Rosowsky, Andre, Forsch, Ronald A, Sibley, Carol Hopkins, Inderlied, Clark B, and Queener, Sherry F
Journal of Medicinal Chemistry 2004. 47(6): 1475-1486
20. 43016 OI-LS-291; WOS-OI-2/29/2004
Novel heteroarotinoids as potential antagonists of Mycobacterium bovis BCG
Brown, CW, Liu, SQ, Klucik, J, Berlin, KD, Brennan, PJ, Kaur, D, and Benbrook, DM
J MED CHEM 2004. 47(4): 1008-1017
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188831300024
21. 43017 OI-LS-291; SCIFINDER-OI-3/2/2004
Mice Deficient in LRG-47 Display Increased Susceptibility to Mycobacterial Infection Associated with the Induction of Lymphopenia
Feng, Carl G, Collazo-Custodio, Carmen M, Eckhaus, Michael, Hieny, Sara, Belkaid, Yasmine, Elkins, Karen, Jankovic, Dragana, Taylor, Gregory A, and Sher, Alan
Journal of Immunology 2004. 172(2): 1163-1168
22. 43018 OI-LS-291; SCIFINDER-OI-3/2/2004
Oxazolidinone derivatives as antimicrobials ((Ranbaxy Laboratories Limited, India)
Mehta, Anita, Rudra, Sonali, Raja Rao, Ajjarapu Venkata Subrahmanya, Yadav, Ajay Singh, and Rattan, Ashok
PATENT: WO 2004014392 A1; ISSUE DATE: 20040219
APPLICATION: 2002; PP: 62 pp.
23. 43019 OI-LS-291; WOS-OI-2/29/2004
Telbivudine. Anti-HBV agent
Sorbera, LA, Castaner, J, Castaner, RM, and Bayes, M
DRUG FUTURE 2003. 28(9): 870-879
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188810400004
24. 43020 OI-LS-291; SCIFINDER-OI-3/2/2004
Animal models expressing ICAM-1 domains and uses for screening drugs for human rhinovirus infection ((Glaxo Group Limited, UK)
Blair, Edward Duncan, Clarke, Neil James, Johnston, Sebastian Lennox, and Rowlands, David John
PATENT: WO 2004009810 A2; ISSUE DATE: 20040129
APPLICATION: 2003; PP: 42 pp.
25. 43021 OI-LS-291; SCIFINDER-OI-3/2/2004
Preparation of 2-amino-9-(2-hydroxymethylcyclopropylidenemethyl)-purines as antiviral agents((Wayne State University, USA and The Regents of the University of Michigan))
Zemlicka, Jiri and Drach, John C
PATENT: WO 2004006867 A2; ISSUE DATE: 20040122
APPLICATION: 2003; PP: 36 pp.
26. 43022 OI-LS-291; SCIFINDER-OI-3/2/2004
Pyrimidones with antiviral properties ((Axxima Pharmaceuticals Aktiengesellschaft, Germany and 4SC AG))
Missio, Andrea, Herget, Thomas, Aschenbrenner, Andrea, Kramer, Bernd, Leban, Johann, and Wolf, Kristina
PATENT: EP 1389461 A1; ISSUE DATE: 20040218
APPLICATION: 2002-18357; PP: 46 pp.
27. 43023 OI-LS-291; WOS-OI-2/29/2004
Structure and fungicidal activity of a synthetic antimicrobial peptide, P18, and its truncated peptides
Lee, DG, Hahm, KS, and Shin, SY
BIOTECHNOL LETT 2004. 26(4): 337-341
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188852800014
28. 43024 OI-LS-291; WOS-OI-2/29/2004
Evidence of metyrapone reduction by two Mycobacterium strains shown by H-1 NMR
Combourieu, B, Besse, P, Sancelme, M, Maser, E, and Delort, AM
BIODEGRADATION 2004. 15(2): 125-132
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188875600005
29. 43025 OI-LS-291; SCIFINDER-OI-3/2/2004
Treatment of herpes simplex virus infections
Brady, Rebecca C and Bernstein, David I
Antiviral Research 2004. 61(2): 73-81
30. 43026 OI-LS-291; WOS-OI-3/7/2004
Review: Multidrug-resistant tuberculosis: public health challenges
Coker, RJ
TROP MED INT HEALTH 2004. 9(1): 25-40
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189083600004
31. 43027 OI-LS-291; SCIFINDER-OI-3/2/2004
Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase
Deszcz, Luiza, Seipelt, Joachim, Vassilieva, Elena, Roetzer, Andreas, and Kuechler, Ernst
FEBS Letters 2004. 560(1-3): 51-55
32. 43028 OI-LS-291; WOS-OI-3/7/2004
Epidemiology of tuberculosis
Bouvet, E, Abiteboul, D, Antoun, F, Bessa, Z, Billy, C, Dautzenberg, B, Decludt, B, Gaudelus, J, Jarlier, V, LerasLe S, Siruguet, O, and Vincent, V
REV MAL RESPIR 2003. 20(6): S13-S104
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188786800003
33. 43029 OI-LS-291; SCIFINDER-OI-3/2/2004
The hepatitis C virus replicase: Insights into RNA-dependent RNA replication and prospects for rational drug design
Frick, David N
Current Organic Chemistry 2004. 8(3): 223-241
34. 43030 OI-LS-291; WOS-OI-3/7/2004
Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate
McKercher, G, Beaulieu, PL, Lamarre, D, LaPlante, S, Lefebvre, S, Pellerin, C, Thauvette, L, and Kukolj, G
NUCLEIC ACIDS RES 2004. 32(2): 422-431
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188989000012
35. 43031 OI-LS-291; SCIFINDER-OI-3/2/2004
Inhibition of the subgenomic hepatitis C virus replicon in Huh-7 cells by 2'-deoxy-2'-fluorocytidine
Stuyver, Lieven J, McBrayer, Tamara R, Whitaker, Tony, Tharnish, Phillip M, Ramesh, Mangala, Lostia, Stefania, Cartee, Leanne, Shi, Junxing, Hobbs, Ann, Schinazi, Raymond F, Watanabe, Kyoichi A, and Otto, Michael J
Antimicrobial Agents and Chemotherapy 2004. 48(2): 651-654
36. 43032 OI-LS-291; WOS-OI-3/7/2004
Evidence for radical formation at Tyr-353 in Mycobacterium tuberculosis catalase-peroxidase (KatG)
Zhao, XB, Girotto, S, Yu, SW, and Magliozzo, RS
J BIOL CHEM 2004. 279(9): 7606-7612
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189103300030
37. 43033 OI-LS-291; WOS-OI-3/7/2004
The YefM antitoxin defines a family of natively unfolded proteins - Implications as a novel antibacterial target
Cherny, I and Gazit, E
J BIOL CHEM 2004. 279(9): 8252-8261
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189103300107
38. 43034 OI-LS-291; WOS-OI-3/7/2004
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency
Beaulieu, PL, Bos, M, Bousquet, Y, DeRoy, P, Fazal, G, Gauthier, J, Gillard, J, Goulet, S, McKercher, G, Poupart, MA, Valois, S, and Kukolj, G
BIOORG MED CHEM LETT 2004. 14(4): 967-971
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188963600027
39. 43035 OI-LS-291; WOS-OI-3/7/2004
Synthesis and antifungal activity of 3,5-disubstituted phenyl imino-1,2,4-triazoles
Siddiqui, AA, Islam, MU, and Siddiqui, N
ASIAN J CHEM 2004. 16(1): 534-536
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188935500090
40. 43036 OI-LS-291; WOS-OI-3/7/2004
Inhibitors of the hepatitis C virus NS5b RNA-dependent RNA polymerase.
Beaulieu, PL, Austel, V, Bos, M, Bousquet, Y, Fazal, G, Gauthier, J, Gillard, J, Goulet, S, LaPlante, S, Poupart, MA, Lamarre, D, Lefebvre, S, McKercher, G, Marquis, M, Pause, A, Pellerin, C, and Kukolj, G
ABSTR PAP AM CHEM S 2003. 226: U4
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062500022
41. 43037 OI-LS-291; WOS-OI-3/7/2004
Hepatitis CNS3 center dot 4A protease inhibitors: Design of reversible covalent warheads.
Perni, RB, Britt, SD, Court, JJ, Courtney, LF, Deininger, DD, Farmer, LJ, Gates, CA, Harbeson, SL, Kim, JL, Levin, R, Moon, YC, Luong, YP, O'Malley, E, Pitlik, J, Rao, BG, Van Drie, JH, Tung, RD, and Thomson, JA
ABSTR PAP AM CHEM S 2003. 226: U18
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062500098
42. 43038 OI-LS-291; WOS-OI-3/7/2004
Hepatitis CNS3 center dot 4A protease inhibitors: Extensive structure-activity relationship exploration of potent, covalent ketoamide based inhibitors.
Pitlik, J, Britt, SD, Cottrell, KC, Court, JJ, Courtney, LF, Deininger, DD, Gates, CA, Lin, C, Lin, K, Luong, YP, Perni, RB, Rao, BG, Thomson, JA, Tung, RD, and Wei, YY
ABSTR PAP AM CHEM S 2003. 226: U18
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062500099
43. 43039 OI-LS-291; WOS-OI-3/7/2004
Synthesis and SAR of 2-(4,5-dihydroxy-6-carboxy-pyrimidinyl) thiophenes as inhibitors of the hepatitis C virus NS5B polymerase.
Malancona, S, Attenni, B, Colarusso, S, Conte, I, Harper, S, Summa, V, Altamura, S, Koch, U, Matassa, VG, and Narjes, F
ABSTR PAP AM CHEM S 2003. 226: U22-U23
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062500123